Advertisement
Salesforce
Salesforce

The Scientist

» cancer and evolution

Most Recent

image: Bones Won’t Be Buried Yet

Bones Won’t Be Buried Yet

By | May 10, 2012

Two 9,000-year-old skeletons will be held by University of California, San Diego, officials—rather than turned over to American Indians for reburial—until a lawsuit is settled.

6 Comments

image: Doubled Gene Boosted Brain Power

Doubled Gene Boosted Brain Power

By | May 7, 2012

Human-specific duplications of a gene involved in brain development may have contributed to our species’ unique intelligence.

6 Comments

image: Legislating Negative Result Reporting

Legislating Negative Result Reporting

By | May 7, 2012

A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.

2 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: A New Branch of Life?

A New Branch of Life?

By | May 1, 2012

Researchers investigate a microorganism that may warrant a new eukaryotic kingdom in the classification of life.

4 Comments

image: Spot the Moth

Spot the Moth

By | May 1, 2012

It’s a well-known story: The peppered moth’s ancestral typica phenotype is white with dark speckles. 

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

image: Burgers and Flies

Burgers and Flies

By | May 1, 2012

Inspired by Darwin, Mohamed Noor has uncovered the molecular dance by which a single species becomes two.

10 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2012

Masters of the Planet, Learning from the Octopus, Darwin’s Devices, and Psychology’s Ghosts

2 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Hamamatsu
Hamamatsu
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies